Suppr超能文献

长期比较植入 Collamer 透镜穹顶和并发症,有中央孔和无中央孔用于高度近视矫正:5 年。

Long-term Comparison of Vault and Complications of Implantable Collamer Lens with and without a Central Hole for High Myopia Correction: 5 Years.

机构信息

Ophthalmology, Fudan University Eye Ear Nose and Throat Hospital Shanghai, China.

National Health Commission Key Laboratory of Myopia, Fudan University, Shanghai, China.

出版信息

Curr Eye Res. 2022 Apr;47(4):540-546. doi: 10.1080/02713683.2021.2012202. Epub 2021 Dec 12.

Abstract

PURPOSE

To investigate the long-term safety, efficacy, stability, vault, and complications of implantable collamer lens with (ICL V4c) and without (ICL V4) a central hole for correcting high myopia.

METHODS

78 eyes (40 patients) underwent ICL V4c implantation and 78 eyes (48 patients) underwent ICL V4 implantation were enrolled. They were followed up for 5 years of the uncorrected and corrected distance visual acuity, spherical equivalent (SE), axial length, intraocular pressure, endothelial cell density and vault.

RESUITS

The safety indices of the ICL V4c and V4 groups at 5 years were 1.25 ± 0.40 and 1.31 ± 0.40, respectively ( = .353). The efficacy indices were 0.90 ± 0.29 and 1.00 ± 0.44, respectively ( = .098). The preoperative, 1 month and 5 year postoperative logMAR UDVAs were respectively 1.54 ± 0.48, 0.11 ± 0.17, and 0.20 ± 0.26 in the V4c group and 1.56 ± 0.44, 0.14 ± 0.19, and 0.22 ± 0.26 in the V4 group ( = .703, 0.329, 0.585). The logMAR CDVAs were resepectively 0.13 ± 0.18, 0.02 ± 0.11, and 0.05 ± 0.16 in the V4c group and 0.18 ± 0.22, 0.05 ± 0.14, and 0.09 ± 0.21 in the V4 group ( = .128, 0.169, 0.229). The SE were resepectively -15.10 ± 4.32 D, -0.71 ± 1.31 D and -1.65 ± 1.30 D in the V4c group and -15.44 ± 3.51 D, -0.61 ± 1.12 D and -1.40 ± 1.30 D in the V4 group ( = .585, 0.637, 0.296). The mean vault reduced by 97.31 ± 136.61 μm in the V4c group and by 99.74 ± 245.83 μm in the V4 group. Three eyes (3.85%) with mid-periphery anterior subcapsular opacification in the V4c group and two (2.56%) with cataract, one (1.28%) with central anterior subcapsular opacification in the V4 group were observed. The CDVA of 20/40 was obtained in the two cataract eyes after phacoemulcification and intraocular lens implantation.

CONCLUSION

Long-term ICL V4c and ICL V4 implantations are safe, effective, and stable for high myopia correction. ICL V4c can potentially reduce the risk of lens opacification and may be more tolerant to low vault than ICL V4.

摘要

目的

研究带(ICL V4c)和不带(ICL V4)中央孔的可植入Collamer 透镜植入矫正高度近视的长期安全性、疗效、稳定性、拱高和并发症。

方法

78 只眼(40 例)行 ICL V4c 植入,78 只眼(48 例)行 ICL V4 植入。随访 5 年,观察未矫正和矫正远距视力、等效球镜(SE)、眼轴长度、眼压、内皮细胞密度和拱高。

结果

ICL V4c 和 V4 组 5 年的安全指数分别为 1.25±0.40 和 1.31±0.40( =0.353)。疗效指数分别为 0.90±0.29 和 1.00±0.44( =0.098)。V4c 组术前、术后 1 个月和 5 年的 logMAR UDVA 分别为 1.54±0.48、0.11±0.17 和 0.20±0.26,V4 组分别为 1.56±0.44、0.14±0.19 和 0.22±0.26( =0.703,0.329,0.585)。V4c 组术前、术后 1 个月和 5 年的 logMAR CDVA 分别为 0.13±0.18、0.02±0.11 和 0.05±0.16,V4 组分别为 0.18±0.22、0.05±0.14 和 0.09±0.21( =0.128,0.169,0.229)。SE 分别为 -15.10±4.32 D、-0.71±1.31 D 和 -1.65±1.30 D 的 V4c 组和 -15.44±3.51 D、-0.61±1.12 D 和 -1.40±1.30 D 的 V4 组( =0.585,0.637,0.296)。V4c 组拱高减少 97.31±136.61 μm,V4 组拱高减少 99.74±245.83 μm。V4c 组有 3 眼(3.85%)出现周边前皮质下混浊,2 眼(2.56%)出现白内障,1 眼(1.28%)出现中央前皮质下混浊。2 只白内障眼在超声乳化白内障吸除联合人工晶状体植入术后获得 20/40 的 CDVA。

结论

长期 ICL V4c 和 ICL V4 植入矫正高度近视是安全、有效、稳定的。与 ICL V4 相比,ICL V4c 可能降低晶状体混浊的风险,对低拱高的耐受性可能更强。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验